New York State Common Retirement Fund
AARD

New York State Common Retirement Fund’s Aardvark Therapeutics AARD Stock Holding History

New York State Common Retirement Fund’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,823
Closed -$14.4K – 3355
2026
Q1 		$14.4K Hold
3,823
– – ﹤0.01% 3048
2025
Q4 		$50.2K Hold
3,823
– – ﹤0.01% 2906
2025
Q3 		$50.8K Sell
3,823
-3,477
-48% -$39.2K ﹤0.01% 2947
2025
Q2 		$98.7K Buy
+7,300
New +$75.2K ﹤0.01% 2670

Other funds holding AARD

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HHCP
Hilton Head Capital Partners Hilton Head Island, South Carolina $198M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

New York State Common Retirement Fund's AARD Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of Aardvark Therapeutics (AARD) in Q2 2026, closing a stake of 3,823 shares — an estimated $14.4K sold.

New York State Common Retirement Fund first reported a position in AARD in Q2 2025 and held it in 4 quarters. The position peaked at $98.7K in Q2 2025. 13 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining Aardvark Therapeutics position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 3,823 Aardvark Therapeutics shares in Q2 2026, an estimated $14.4K.
  • New York State Common Retirement Fund first reported a position in Aardvark Therapeutics in Q2 2025 and held it in 4 quarters.
  • New York State Common Retirement Fund's Aardvark Therapeutics position peaked at $98.7K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.